Publications by authors named "Ellen Wientjens"

Claim this Profile
C
C-terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.
Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg, Anne Paulien Drenth, Jessica K Lee, Ellen Wientjens

Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.
Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko, Lukasz Wieteska, Sjors M Kas, Ellen Wientjens

Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.
Julia M Houthuijzen, Roebi de Bruijn, Eline van der Burg, Anne Paulien Drenth, Ellen Wientjens

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M Kas, Frank Rolfs, Ellen Wientjens

Nature· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M Kas, Frank Rolfs, Ellen Wientjens

Nature· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547.
Sjors M Kas, Julian R de Ruiter, Koen Schipper, Eva Schut, Lorenzo Bombardelli, Ellen Wientjens

Cancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.
Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, Ingrid van der Heijden, Inger Brandsma, Ellen Wientjens

J Clin Invest· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Mirjam C Boelens, Micha Nethe, Sjoerd Klarenbeek, Julian R de Ruiter, Eva Schut, Ellen Wientjens

Cell Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Peter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, Rinske Drost, Christiaan N Klijn, Ellen Wientjens

Cancer Discov· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.
Ewa Malgorzata Michalak, Karim Nacerddine, Alexandra Pietersen, Vincent Beuger, Inka Pawlitzky, Ellen Wientjens

Stem Cells· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.
Janneke E Jaspers, Ariena Kersbergen, Ute Boon, Wendy Sol, Liesbeth van Deemter, Ellen Wientjens

Cancer Discov· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.
Rinske Drost, Peter Bouwman, Sven Rottenberg, Ute Boon, Eva Schut, Ellen Wientjens

Cancer Cell· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.
Anders H Lund, Geoffrey Turner, Alla Trubetskoy, Els Verhoeven, Ellen Wientjens

Nat Genet· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis